| 000 | 01458 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513153654.0 | ||
| 264 | 0 | _c19981123 | |
| 008 | 199811s 0 0 eng d | ||
| 022 | _a0165-6147 | ||
| 024 | 7 |
_a10.1016/s0165-6147(98)01243-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTaylor, C W | |
| 245 | 0 | 0 |
_aPharmacological analysis of intracellular Ca2+ signalling: problems and pitfalls. _h[electronic resource] |
| 260 |
_bTrends in pharmacological sciences _cSep 1998 |
||
| 300 |
_a370-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xpharmacology |
| 650 | 0 | 4 |
_aCalcium Channels _xchemistry |
| 650 | 0 | 4 |
_aCalcium-Calmodulin-Dependent Protein Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCell Membrane _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInositol 1,4,5-Trisphosphate Receptors |
| 650 | 0 | 4 |
_aIntracellular Membranes _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Cytoplasmic and Nuclear _xchemistry |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aType C Phospholipases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
| 700 | 1 | _aBroad, L M | |
| 773 | 0 |
_tTrends in pharmacological sciences _gvol. 19 _gno. 9 _gp. 370-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0165-6147(98)01243-7 _zAvailable from publisher's website |
| 999 |
_c9750560 _d9750560 |
||